Current synopsis on siRNA therapeutics as a novel anti-cancer and antiviral strategy: Progress and challenges
This article stated the development in the RNA polymer and also provides some examples of their diagnostic applications and therapeutics special emphasis on the anti-cancer and antiviral strategy. Patisiran and Givosiran are the recently approved si-RNA based products available in the market.PMID:35578839 | DOI:10.2174/1389201023666220516120432
Source: Current Pharmaceutical Biotechnology - Category: Biotechnology Authors: Sanjay Sharma Rupesh K Gautam Abhishek Kanugo Dinesh Kumar Mishra Mohammad Amjad Kamal Source Type: research
More News: Biotechnology | Cancer | Cancer & Oncology | Cancer Therapy | Genetics | Nanotechnology | SARS